Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation

Clinical and Translational Oncology

Volumn 14, Issue 9, 2012, Pages 682-688

  Pérez Ruiz, Elisabeth ^a   Cazorla, O ^b   Redondo, M ^a   Perez L ^c   Alvarez M ^c   Gallego, E ^c   Trigo, J M ^c   Medina, J A ^c   Matilla, A ^c   Rueda, A ^a  

^a HOSPITAL COSTA DEL SOL   (Spain)

^b Division of Otolaryngology   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Cyclooxygenase 2; Phonation conservation; Squamous cell carcinoma of the larynx

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHONATION; PROGNOSIS; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR BIOPSY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 2; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHONATION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84871226396     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0859-2     Document Type: Article

References (25)

1. Rodrigo Tapia JP (2002) Incidencia y etiología de los carcinomas de cabeza y cuello. In: Suárez Nieto C (ed) Oncología de cabeza y cuello. Medicina stm, Barcelona, pp 1-14
2. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiotherapy compared with surgery plus radiotherapy in patients with advances laryngeal cancer. N Engl J Med 324:1685-1690
3. Schantz SP, Harrison LB, Forastiere AA (1997) Tumors of the nasal cavity and paranasal sinuses, nasophatrinx, oral cavity and oropharynx. In: De vita VT, Hellman S, Rosenberg SA (eds) Principles of oncology, 5th edn. Lippincott, Philadephia, pp 741-801
4. Liu CH, Chang SH, Narko K et al (2001) Over-expression of cyclooxigenasa (Cox)-2 is sufficient to induce tumorigenesis in transgenic. Biol Chem 276:18563-18569
5. Masferrer JL, Leía KM, Kaki AT et al (2000) Antiogenic and antitumor activities of cyclooxygenase 2 inhibitors. Cancer Res 60:1306-1311
6. Ristimaki A, Sivula A, Lunfin J et al (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62:632-635
7. Shim JY et al (2003) Overexpression of cyclooxigenase-2 is associated with breast carcinoma and its poor prognostic factor. Mod Pathol 16:1199-1204
8. Sano H, Kawahito Y, Wilder RL et al (1995) Expresión of cyclooxigenase-1 and-2 in human colorectal cancer. Cancer Res 55:3789-3789
9. Yoshimatsu K, Nasser K, Golijanin D et al (2001) Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin Cancer Res 7:2669-2674
10. Karmali RA, Wustrow T, Thaler HT, Strong EW (1984) Prostaglandins in carcinomas of the head and neck. Cancer Lett 22:333-336
11. Jung TK, Berlinger NT, Juhn SK (1985) Prostaglandins in squamous cell of the head and neck: a preliminary study. Laryngoscope 95:307-312
12. Tsujii M, Kawano S, Tsuji S et al (1998) Cyclooxygenase regulates angio-genesis induced by colon cancer cells. Cell 93:705-716
13. Rueda A, Cazorla O, Pérez L et al (2011) Vascular endotelial growth factor and vascular endotelial growth factor receptor-2 tumor expresión in patients with advanced laryngeal cancer alter induction chemotherapy for organ preservation. Head Neck 33:808-816
14. Kyzas PA, Stefanou D, Agnantis NJ (2005) COX-2 expression correlates with VEGF-C and lymph node metastases in patients with head and neck squamous cell carcinoma. Mod Pathol 18:153-160
15. Xu CZ, Dong P, Li XY et al (2009) Expression and clinical significante of hypoxia-inducible factor-1alpha and cyclooxigenase-2 in laryngeal squamous cell carcinoma. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44:57-62
16. Fosslien E (2000) Molecular pathology of cyclooxigenase-2 in neoplasia. Ann Clin Lab Sci 30:3-21
17. Tsujii M, DuBois RN (1995) Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501
18. Dohadwala M, Luo J, Zhu L et al (2001) Non-small cell lung cancer cyclo-oxigenase 2 dependent invasión is mediated by CD44. j. Biol Chem 276:809-812
19. Davies G et al (2003) Correlation between cyclooxigenase-2 expression and angiogenesis in human breast cancer. Clin Cancer Res 9:2651-2656
20. Ranelletti FO et al (2001) Prognostic significance of cyclooxygenase-2 in lar-yngeal squamous cell carcinoma. Int J Cancer 95:343-349
21. Sackett MK, Bairati I, Meyer F et al (2008) Prognostic significance of cyclo-oxygenase-2 overxpression in glottis cancer. Clin Cancer Res 14:67-73
22. Cho EI, Kowalski DP, Sasaki CT et al (2004) Tissue microarray analysis reveals prognostic significance of COX-2 expression for local relapse in T1-2N0 larynx cancer treated with primary radiation therapy. Laryngoscope 114:2001-2008
23. Danneberg AJ, Altorki NK, Boyle JO et al (2001) Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2:544-551
24. Soo R, Putti T, Tao Q et al (2005) Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. Arch Otolaryngol Head Neck Surg 131:147-152
25. Qin G, Liang Q, Yu L et al (2010) Expression and significance of COX-2 and S-100 positive dendritic cell in laryngeal carcinoma. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24:101-104